<level>
  <type>section</type>
  <num>48-851.01</num>
  <heading>Definitions.</heading>
  <text>For the purposes of this chapter, the term:</text>
  <level>
    <num>(1)</num>
    <text>"Health care facility" means a hospital, assisted living facility, nursing home, or institutional pharmacy.</text>
  </level>
  <level>
    <num>(2)</num>
    <text>"Institutional pharmacy" means that physical portion of a health care facility where drugs, devices, and other materials used in the diagnosis or treatment of injury, illness, and disease are dispensed, compounded, or distributed and pharmaceutical care is provided.</text>
  </level>
  <level>
    <num>(3)</num>
    <text>"Pharmaceutical product" means a drug or biologic for human use regulated by the federal Food and Drug Administration.</text>
  </level>
  <level>
    <num>(4)</num>
    <text>"Retail pharmacy" means a pharmacy that provides services to the public on an outpatient basis.</text>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>History</heading>
      <text>(Mar. 5, 2010, D.C. Law 18-112, ยง 2, 56 DCR 9378.)</text>
    </level>
    <level>
      <heading>Legislative History of Law 18-112</heading>
      <text>Law 18-112, the "Unused Pharmaceutical Safe Disposal Act of 2009", was introduced in Council and assigned Bill No. 18-313, which was referred to the Committee on Health. The Bill was adopted on first and second readings on November 3, 2009, and December 1, 2009, respectively. Signed by the Mayor on December 11, 2009, it was assigned Act No. 18-242 and transmitted to both Houses of Congress for its review. D.C. Law 18-112 became effective on March 5, 2010.</text>
    </level>
    <level>
      <heading>Delegation of Authority</heading>
      <text>Delegation of Authority Pursuant to the Unused Pharmaceutical Safe Disposal Act of 2009, see Mayor's Order 2011-90, May 6, 2011 (58 DCR 4176).</text>
    </level>
  </level>
</level>
